Papers
5
Total Citations
40
H-Index
4
About
Dr. Peter Sparwasser is a pioneering urologic surgeon whose research centers on advancing minimally invasive robotic techniques for the treatment of urologic cancers, with a particular focus on upper tract urothelial cancer (UTUC) and testicular cancer. His most significant contribution is the development and validation of the completely robot-assisted retroperitoneal nephroureterectomy with bladder cuff—a first-in-field technique that avoids entering the peritoneal cavity. This work, detailed in his most-cited paper (21 citations), has been further supported by the first direct comparison of retroperitoneal versus transperitoneal approaches for this procedure. Dr. Sparwasser has also demonstrated the safety of robotic surgery during the COVID-19 pandemic (7 citations), providing critical guidance for maintaining surgical care during global health crises. His impact extends to national-level research, including the GRAND study, which assessed current trends and outcomes of retroperitoneal lymph node dissection for testicular cancer across Germany. With additional work on robot-assisted partial nephrectomy, Dr. Sparwasser is establishing himself as a leading voice in refining retroperitoneal robotic approaches to improve patient recovery and surgical outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5